Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial

NCT02454751 is registered in ClinicalTrials.gov with St. Boniface Hospital as lead sponsor.

NCT NCT02454751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02454751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial
Lead sponsor
St. Boniface Hospital
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2015
Completion date
September 15, 2017
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure, dyspnea